Literature DB >> 12806015

The TREX2 3'-->5' exonuclease physically interacts with DNA polymerase delta and increases its accuracy.

Igor V Shevelev1, Kristijan Ramadan, Ulrich Hübscher.   

Abstract

Proofreading function by the 3'-->5' exonuclease of DNA polymerase delta (pol delta) is consistent with the observation that delta efficiency of the associated exonuclease can lead to a strong mutation phenotype, high error rates during DNA replication, and ultimately cancer. We have isolated pol delta from isotonic (pol delta(i)) and detergent (pol delta(d)) calf thymus extracts. Pol delta had a 20-fold higher ratio of exonuclease to DNA polymerase than pol deltai. This was due to the physical association of the TREX2 3'-->5' exonuclease to pol delta(d), which was missing from pol delta(i). Pol delta(d) was fivefold more accurate than pol i under error-prone conditions (1 mM dGTP and 20 dATP, dCTP, and dTTP) in a M13mp2 DNA forward mutation assay, and fourfold more accurate than pol delta(i) under error-prone conditions (1 mM dGTP and 20 microM dATP, dCTP, and dTTP) in a M13mp2 DNA forward mutation assay, and fourfold more accurate in an M13mp2T90 reversion assay. Under error-free conditions (20 microM each of the four dNTPs), however, both polymerases showed equal fidelity. Our data suggested that autonomous 3' --> 5' exonucleases, such as TREX2, through its association with pol delta can guarantee high fidelity under difficult conditions in the cell (e.g., imbalance of dNTPs) and can add to the accuracy of the DNA replication machinery, thus preventing mutagenesis.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12806015      PMCID: PMC6009725          DOI: 10.1100/tsw.2002.99

Source DB:  PubMed          Journal:  ScientificWorldJournal        ISSN: 1537-744X


  9 in total

Review 1.  Regulation of the DNA replication fork: a way to fight genomic instability.

Authors:  Magali Toueille; Ulrich Hübscher
Journal:  Chromosoma       Date:  2004-08-06       Impact factor: 4.316

2.  The Epstein-Barr virus replication protein BBLF2/3 provides an origin-tethering function through interaction with the zinc finger DNA binding protein ZBRK1 and the KAP-1 corepressor.

Authors:  Gangling Liao; Jian Huang; Elizabeth D Fixman; S Diane Hayward
Journal:  J Virol       Date:  2005-01       Impact factor: 5.103

Review 3.  PARP-1 and its associated nucleases in DNA damage response.

Authors:  Yijie Wang; Weibo Luo; Yingfei Wang
Journal:  DNA Repair (Amst)       Date:  2019-07-08

4.  Trex2 enables spontaneous sister chromatid exchanges without facilitating DNA double-strand break repair.

Authors:  Lavinia C Dumitrache; Lingchuan Hu; Mi Young Son; Han Li; Austin Wesevich; Ralph Scully; Jeremy Stark; Paul Hasty
Journal:  Genetics       Date:  2011-05-05       Impact factor: 4.562

5.  TREX1 acts in degrading damaged DNA from drug-treated tumor cells.

Authors:  Chuan-Jen Wang; Wing Lam; Scott Bussom; Hua-Mei Chang; Yung-Chi Cheng
Journal:  DNA Repair (Amst)       Date:  2009-07-18

6.  High fidelity and lesion bypass capability of human DNA polymerase delta.

Authors:  Michael W Schmitt; Yoshihiro Matsumoto; Lawrence A Loeb
Journal:  Biochimie       Date:  2009-06-18       Impact factor: 4.079

7.  siRNA screening identifies differences in the Fanconi anemia pathway in BALB/c-Trp53+/- with susceptibility versus C57BL/6-Trp53+/- mice with resistance to mammary tumors.

Authors:  M Böhringer; K Obermeier; N Griner; D Waldraff; E Dickinson; K Eirich; D Schindler; M Hagen; D J Jerry; L Wiesmüller
Journal:  Oncogene       Date:  2013-02-25       Impact factor: 9.867

8.  Biochemical and cellular characteristics of the 3' -> 5' exonuclease TREX2.

Authors:  Ming-Jiu Chen; Sheng-Mei Ma; Lavinia C Dumitrache; Paul Hasty
Journal:  Nucleic Acids Res       Date:  2007-04-10       Impact factor: 16.971

9.  Distinct mutational signatures characterize concurrent loss of polymerase proofreading and mismatch repair.

Authors:  N J Haradhvala; J Kim; Y E Maruvka; P Polak; D Rosebrock; D Livitz; J M Hess; I Leshchiner; A Kamburov; K W Mouw; M S Lawrence; G Getz
Journal:  Nat Commun       Date:  2018-05-01       Impact factor: 14.919

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.